NA Proactive news snapshot: NetCents Technology, Codebase Ventures, Victory Resources, BioLargo, Mawson Gold - UPDATE...

NetCents Technology Inc. (CSE:NC) (FRA:26N) (OTCQB:NTTCF), the cryptocurrency payments technologies company, has announced the recruitment of Nilang Vyas as its chief technical officer (CTO). In his new role, NetCents said Vyas will drive a hybrid approach to innovation, deploying technologies that will enhance the capabilities of the company's current product offering and technologies that will improve business efficiencies. Before joining NetCents, Vyas was the chief technology officer of Decentral, an innovation hub for disruptive and decentralized technologies, notably spawning Ethereum and Jaxx Liberty. Codebase Ventures Inc. (CSE:CODE) (FRA:C5B) (OTCQB:BKLLF) said it has completed the final tranche of its non-brokered private placement which raised in total $1,353,965. In the second and final tranche the company raised proceeds of $666,965 through the sale of 13,339,300 units, after having raised proceeds of $687,000 through the sale of 13,740,000 units in the first tranche  The group said the proceeds of the financing will be used for general working capital and to fund future investments. Life Sciences Investor Forum has announced that the presentations from its December 17, 2020, conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. The virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”. Investors can register of log-in at: https://bit.ly/2Wqsir2 Victory Resources Corporation (CSE:VR) (OTCMKTS:VRCFF) (FRA:VR61) said Monday that it has appointed experienced mining engineer David Deering to the company’s board as vice president of exploration. The Vancouver-headquartered mining firm said this important addition to its leadership team, would boost the group's mining exploration capabilities as it advances work programs on existing assets and evaluates the acquisition of new projects. Deering has garnered experience in roles such as CEO of Meadow Bay Capital Corporation and as a consulting engineer for MINDEVINC and Pamicon Developments. KushCo Holdings Inc (OTCQX:KSHB) announced that it will collaborate with Mascot Books to collect and distribute more than 100,000 books for children across the United States, as part of the company's “Children in the Community Book Drive.” KushCo said the partnership represents the latest initiative from its KushCares platform, which has helped strengthen local communities, empower KushCo employees, and positively impact the legal cannabis and CBD industries through various ESG and CSR initiatives. Pacific Empire Minerals Corp (CVE:PEMC) (OTCQB:PEMSF) has inked a binding agreement to partner up on its Pinnacle copper-gold project in north-central British Columbia. The deal was first reported in August this year and has now been sealed. 1111 Acquisition Corp will receive an exclusive option to earn up to a 70% interest in the 14,040 hectare asset. Under the terms, it must spend C$5.7 million on exploration, pay Pacific Empire a total of C$375,000 in cash and issue it with 3.5 million shares by the fourth anniversary of the signing of the definitive deal. Q BioMed, Inc. (OTCQB:QBIO) has announced that its technology partner Mannin Research Inc., a private Canadian biotechnology company, is a member of the Canadian national COVID Cloud consortium.  Mannin Research is developing a host-directed approach to treating patients with COVID-19 suffering from Acute Respiratory Distress Syndrome (ARDS). It is contributing to the development of the COVID-19 platform so as to provide information that will improve the effectiveness of its novel therapeutic for COVID-19 patients, code-named MAN-19.   The platform will be used by Mannin Research to help understand, predict, and treat coronavirus (COVID-19) with molecular precision. China Xiangtai Food Co Ltd (NASDAQ:PLIN) reported fiscal 2020 revenue of $110.6 million, an 11.6% increase from 2019, which it attributed primarily to feed raw materials sales from its acquisition of Chongqing Ji Mao Cang Feed Co Ltd. China Xiangtai Food Co noted that revenues from supermarket and grocery stores increased by 51% to $5.8 million during 2020, as the company said it raised its prices, along with other food suppliers, due to temporary supply shortages as a result of Chinese New Year and COVID-19. VR Resources Ltd (CVE:VRR) (OTCQB:VRRCF) (FRA:5VR) reported that it has completed the 2020 field season at its Reveille silver-copper property in Nevada, in which a total of 166 soil samples and 63 rock samples were collected during the last three weeks. The company said it expects to receive all of the geochemical results from the soil and rock sampling completed in November and December by January 2021. Alpine 4 Technologies Ltd (OTCQB:ALPP) said founder of its recently acquired drone group Impossible Aerospace (IA) Spencer Gore had welcomed the US government's move to blacklist Chinese drone maker DJI. DJI represents between 70 and 80% of the commercial drone market so this creates vast opportunities for American firms like Impossible Aerospace (IA), the Phoenix, Arizona based tech holding company suggested. The US Department of Commerce has added DJI to the "Entity List" of Chinese companies prohibited from the procurement of advanced American technology. Vuzix Corporation (NASDAQ:VUZI) (FRA:V7XN) announced Monday that its Vuzix Blade Smart Glasses were used to aid the first augmented reality (AR) total knee replacement surgery conducted in the US. The AR knee replacement platform from Medacta, known as NextAR TKA, utilizes a preoperative CT scan of the patient's knee for surgical planning and AR glasses during surgery. The Vuzix Blade Smart Glasses allow the orthopedic surgeon to visualize the structures of the knee and track progress in real time directly on the operative field, without having to look over at a computer screen. The operation was completed by an orthopedic surgeon in New York at the Hospital for Special Surgery Revive Therapeutics Ltd (CSE:RVV) (OTC:RVVTF) signed a non-binding letter of intent Sunday to acquire full rights to PharmaTher Inc’s psilocybin-related intellectual property, the company announced Monday. PharmaTher, a subsidiary of Newscope Capital Corporation (CSE:PHRM) (OTCPINK:PHRRF), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals. Revive will acquire a trio of provisional patent applications with the US Patent and Trademark Office, regarding psilocybin as a treatment for neurological brain injury, cancer and as part of combination therapies. Gevo Inc (NASDAQ:GEVO) announced Monday that it has optioned the right to purchase nearly 239 acres of land near Lake Preston, South Dakota for a planned fuel production facility. The Englewood, Colorado-based group also said it met the initial milestone to secure control of a site by the end of this year – meeting the conditions required under the company’s binding Renewable Hydrocarbons Purchase and Sale Agreement with Trafigura Trading LLC signed in August 2020. The agreement – a long term, take or pay contract that is the largest in Gevo’s history – sees Gevo delivering nearly 25 million gallons per year of renewable hydrocarbons. The majority of the product is expected to be low-carbon premium gasoline with a smaller portion of the volume for sustainable aviation fuel, starting in 2023. BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and a full-service environmental engineering company, has announced that its current fourth-quarter revenues of approximately $750,000 will result in new quarterly and annual records for the company. In addition to setting revenue records, BioLargo also significantly reduced its debt obligations during the year. As of December 31, 2019, the group's balance sheet showed approximately $4.6 million in notes payable and lines of credit, not including solely owed obligations of its partially owned subsidiary Clyra Medical. Victory Square Technologies Inc (CSE:VST) (OTCMKTS:VSQTF) (FRA:6F6) announced on Monday that its rapid 15-minute VS SARS CoV-2 antigen test for detecting coronavirus, or SARS-CoV-2 had received a CE mark. This clears the path for the commercial launch, including the marketing, sales and distribution of its white-label VS SARS CoV-2 Antigen Test in the European Union through December 2022. The company explained that its test was deemed in conformity, which indicates that a product complies with all the requirements of European in-vitro diagnostic device legislation.  Exro Technologies Inc. (CVE:EXRO) (OTCMKTS:EXROF), a leading clean technology company which has developed a new class of power electronics for electric motors and batteries, announced that it has completed the technology validation on its Battery Control System (BCS) – formerly known as the intelligent battery management system. The BCS can expand the capabilities of batteries by enabling a greater depth of control on the cells. The cells remaining in a battery at the end of first life can be optimized to rejuvenate the same battery into a new second life. Exro said it can establish a greater depth of control on battery cells because the same principles that govern coil groupings in electric motors can also apply to managing cells in a battery. Mawson Gold Limited (TSE:MAW) (OTCPINK:MWSNF) (FRA:MXR) has reported more high-grade gold and cobalt results from drilling on the Joki East prospect at its huge Rajapalot project in Finland. Eight holes have been completed at the target and mineralization remains open in all directions and now extends over an area of at least 130 metres by 35 metres. Notably, the ore body plunges at 25 degrees to the northwest (NW), which is a similar trend to other mineralized bodies defined at Rajapalot - a project, which hosts numerous gold- cobalt prospects within a 3 kilometre by 4 kilometre area. Marrone Bio Innovations, Inc. (NASDAQ: MBII) has revealed that farmers in Uruguay will have a new solution to grow a more sustainable crop thanks to a new arrangement that will allow PGG Wrightson Seeds (PGGWS), New Zealand’s largest seed company, to distribute the group's line of Pro Farm Technology products.  The recently signed agreement provides PGGWS with exclusive crop dependent selling rights to MBI’s Pro Farm UBP seed treatment line for the next five years (2020-2025) in Uruguay. “South American markets are of key importance to our international expansion plans and this new partnership with PGGWS supports that global growth strategy,” commented Kevin Hammill, Chief Commercial Officer of Marrone Bio Innovations in a statement. “The introduction of our UBP Seed Treatment to the Uruguayan market provides an innovative product that helps farmers establish healthier plants and increase crop yields.” Progressive Planet Solutions Inc (CVE:PLAN) (FRA:ARB3) said it had completed a positive exploration program at its wholly-owned Heffley Creek metals and Pozzolan property in British Columbia this summer, which will help define next year's work. Work this year consisted of 459 soil samples and 271 rock samples, along with prospecting and notably, a nickel and chromium anomalous area has been uncovered ranging from 150 to 300 metres in width and 600 to 800 metres in length.  Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1) said Monday it expects to receive public funding to help develop its flagship drug ARDS-003. The Ottawa-based firm told shareholders that it was recommended for government funding to boost the development program for ARDS-003, which is being investigated as a potential treatment for both sepsis and acute respiratory distress syndrome (ARDS). Derived from cannabinoids, ARDS-003 is designed to prevent and treat ARDS, a severe inflammatory response that could be life-threatening to coronavirus patients. Aurania Resources Ltd (CVE:ARU) (OTCQB:AUIAF) (FRA:20Q) has welcomed a move by the Ecuadorian government to extend the 'initial exploration' phase of a project to compensate for permitting delays. Concessions in the country are granted for 25 years, provided they are kept in 'good standing' by paying annual fees to the state. There is an "initial exploration" phase (which costs US$10 per hectare per year for four years), followed by four-years of so-called 'advanced exploration' (at US$20 a hectare) then two years' of an "economic evaluation" stage, leading to mine construction and mineral production in the rest of the term. On December 9 this year, the Ecuadorian government adopted new legislation that clarifies that the "initial exploration" phase begins not on the date the concession was granted, but when the holder receives the permits required to carry out operations. BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU) announced Monday that it has completed the acquisition of psychedelic biotechnology firm Transcend Biodynamics LLC in an all-stock transaction valued at C$10 million. The deal adds BOL-148, Transcend’s LSD derivative, to BetterLife’s drug pipeline. The company paid 13.3 million shares at C$0.75 per share. “We are very pleased to close our acquisition of Transcend. It is our continual objective to broaden our product scope, and Transcend, with its experienced management team, is a perfect foothold for us in the fast-growing market for psychedelics molecules and complements our existing pipeline of treatments,” BetterLife CEO Ahmed Doroudian said in a statement. NexTech AR Solutions Corp (CSE:NTAR) (OTCQB:NEXCF) (FRA:N29) reported that its CEO Evan Gappelberg recently purchased 250,000 company shares, his fifth stock purchase of the year, for a total 2020 investment of $975,921, or 1,279,885 NexTech common shares. Gappelberg purchased the shares by exercising 250,000 warrants, which adds $175,000 to the company’s balance sheet, bolstering NexTech’s cash and inventory position to more $16 million. Altamira Gold Corp. (CVE:ALTA) (FRA:T6UP) (OTCPINK:EQTRF) said it has received the C$500,000 from Mineracao do Para Ltda. (MAP) following completion of the transfer of title regarding the Crepori gold project which is located in the state of Para in Brazil. The company has retained a 4% net smelter return royalty (NSR) as part of the agreement regarding the Crepori gold project, which is located approximately 5 kilometers (km) north of MAP's small hard-rock gold mining operation which currently produces an estimated 4,200 ounces of gold per year GGX Gold Corp. (CVE:GGX) (OTCQB:GGXXF)( FRA:3SR2) announced that it has closed the non-brokered private placement announced on November 25, 2020, and December 14, 2020, by issuing 3,052,500 units at a price of $0.16 cents per unit for gross proceeds of $488,400. Each flow-through unit will comprise of one common share (which is a flow-through share for Canadian income tax purposes) and one share purchase warrant. Each whole warrant will entitle the holder to purchase one additional common share at the price of $0.20 for 18 months after closing. The term of the warrants may be accelerated in the event that the issuer's shares trade at or above a price of $0.25 cents per share for a period of 10 consecutive days. Proceeds from the private placement will be used for the continued exploration work on the Gold Drop Property in the Greenwood mining camp of south-central British Columbia. All securities issued in connection with the offering will be subject to a hold period expiring April 16, 2021. Sanatana Resources Inc (CVE:STA) said the TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on December 3, 2020, which will see the issue of 4.8 million flow-through shares at a purchase price of 25 cents per share, together with 2.4 million share purchase warrants at an exercise price of 35 cents for a two-year period with five placees. Exro Technologies Inc (CVE:EXRO) said its short form prospectus dated December 8, 2020, was filed with and receipted by the Alberta Securities Commission, and that the Ontario Securities Commission has issued a receipt for the prospectus. The prospectus has also been filed with and accepted by the TSX Venture Exchange which has been advised that closing occurred on December 14, 2020, for gross proceeds of $41,974,998, including gross proceeds from the full exercise of the overallotment option. Pure Gold Mining Inc. (CVE:PGM) (LON:PUR) said it has granted 1,955,000 Incentive Stock Options to directors and certain employees, 975,000 Deferred Share Units (DSUs) to directors and 1,134,930 Restricted Share Units (RSUs) to certain employees pursuant to its Incentive Stock Option, DSU and RSU Plans. The Incentive Stock Options have an exercise price of $2.84 and have a range of vesting periods over three years and expire after five years. The RSU’s are payable in common shares of the company on exercise, have a range of vesting periods over three years and must be redeemed by December 31, 2023, or they expire. The DSU’s vest immediately upon grant and are payable in common shares of the company, upon the holder ceasing to be a director of the company. Binovi Technologies Corp. (CVE:VISN) (OTCQB:BNVIF) (FRA:2EYA) a leader in neuro-vision performance technology, has announced the results from its Annual General and Special Meeting of Shareholders, held on December 16, 2020, at its registered and records office located Suite 3123 - 595 Burrard Street, Vancouver, BC, and by conference call. All nominees listed in the information circular dated November 9, 2020, were elected as directors of the company. In addition, the shareholders approved all of the other resolutions detailed in the circular and put forward at the meeting. GoviEx Uranium (CVE:GXU) (OTCMKTS:GVXXF) said its CEO Daniel Major has given an interview on the Ellis Martin Report. In it, Major shares his perspective on the uranium sector including the supply and demand fundamentals contributing to what he is stating as a bull market. He also discusses recent news with regard to initial geophysical and assay results targeting the company's Falea polymetallic mineralization. Ellis Martin is a shareholder of GoviEx Uranium. To watch the interview, please visit: https://www.abnnewswire.net/press/en/103888/gxu Algernon Pharmaceuticals Inc. (CSE:AGN) (FRA:AGW) (OTCQB:AGNPF), a clinical-stage pharmaceutical development company, has announced that its CEO Christopher J. Moreau and CSO Dr Mark Williams, will be discussing the company’s interim data report for part 2b of its Phase 2b/3 clinical study of Ifenprodil for COVID-19 on an upcoming Streetsmart Live! webcast. They will be joined by Dr Mark Swaim, founder of BIOPUB and Steve Palmer, president and CEO of AlphaNorth Asset Management, as they also discuss upcoming catalysts and events. The Streetsmart Live! webcast will be held Monday, December 21, 2020, hosted at 12.00pm EST. The media and the public can listen to the interview free of charge via the following link: https://www.streetwisereports.com/events/register/?event_id=69&utm_source=AGN_PR